NUR 100: PHARMACOLOGY AND THE
NURSING PROCESS CH 4-6 EXAM WITH
CORRECT QUESTIONS AND ANSWERS
2025
During the development of a new drug, which would be included in the study by the
researcher to prevent any bias or unrealistic expectations of the new drug's usefulness?
a) A placebo
b) FDA approval
c) Informed consent
d) Safety information - CORRECT-ANSWERS ******a) A placebo
To prevent bias that may occur as a result of unrealistic expectations of an
investigational new drug, a placebo is incorporated into the study. The other options are
incorrect. FDA approval, if given, does not occur until after phase III. Informed consent is
required in all drug studies. Safety information is not determined until the study is under
way.
A member of an investigational drug study team is working with healthy volunteers
whose participation will help to determine the optimal dosage range and
pharmacokinetics of the drug. The team member is participating in what type of study?
,a) Phase I
b) Phase II
c) Phase III
d) Phase IV - CORRECT-ANSWERS ******a) Phase I
Phase I studies involve small numbers of healthy volunteers to determine optimal
dosage range and the pharmacokinetics of the drug. The other phases progressively
involve volunteers who have the disease or ailment that the drug is designed to
diagnose or treat.
During discharge patient teaching, the nurse reviews prescriptions with a patient. Which
statement is correct about refills for an analgesic that is classified as Schedule C-III?
a) No prescription refills are permitted.
b) Refills are allowed only by written prescription.
c) The patient may have no more than five refills in a 6-month period.
d) Written prescriptions expire in 12 months. - CORRECT-ANSWERS ******c) The patient
may have no more than five refills in a 6-month period.
, Schedule C-III medications may be refilled no more than five times in a 6-month period.
The patient should be informed of this regulation. No prescription refills are permitted
for Schedule C-II drugs. Requiring refills by written prescription only applies to Schedule
C-II drugs. Schedule C-III prescriptions (written or oral) expire in 6 months.
A patient has been selected as a potential recipient of an experimental drug for multiple
sclerosis. The nurse knows that when informed consent has been obtained, it indicates
which of these?
a) The patient has been informed that he or she will need to stay in the study until it
ends.
b) The patient will be informed of the details of the study as the research continues.
c) The patient will receive the actual drug during the experiment.
d) The patient has had the study's purpose, procedures, and possible benefits as well as
risks involved explained to him. - CORRECT-ANSWERS ******d) The patient has had the
study's purpose, procedures, and possible benefits as well as risks involved explained to
him.
Informed consent involves the careful explanation of the purpose of the study, the
procedures to be used, and the risks involved. The other options do not describe
NURSING PROCESS CH 4-6 EXAM WITH
CORRECT QUESTIONS AND ANSWERS
2025
During the development of a new drug, which would be included in the study by the
researcher to prevent any bias or unrealistic expectations of the new drug's usefulness?
a) A placebo
b) FDA approval
c) Informed consent
d) Safety information - CORRECT-ANSWERS ******a) A placebo
To prevent bias that may occur as a result of unrealistic expectations of an
investigational new drug, a placebo is incorporated into the study. The other options are
incorrect. FDA approval, if given, does not occur until after phase III. Informed consent is
required in all drug studies. Safety information is not determined until the study is under
way.
A member of an investigational drug study team is working with healthy volunteers
whose participation will help to determine the optimal dosage range and
pharmacokinetics of the drug. The team member is participating in what type of study?
,a) Phase I
b) Phase II
c) Phase III
d) Phase IV - CORRECT-ANSWERS ******a) Phase I
Phase I studies involve small numbers of healthy volunteers to determine optimal
dosage range and the pharmacokinetics of the drug. The other phases progressively
involve volunteers who have the disease or ailment that the drug is designed to
diagnose or treat.
During discharge patient teaching, the nurse reviews prescriptions with a patient. Which
statement is correct about refills for an analgesic that is classified as Schedule C-III?
a) No prescription refills are permitted.
b) Refills are allowed only by written prescription.
c) The patient may have no more than five refills in a 6-month period.
d) Written prescriptions expire in 12 months. - CORRECT-ANSWERS ******c) The patient
may have no more than five refills in a 6-month period.
, Schedule C-III medications may be refilled no more than five times in a 6-month period.
The patient should be informed of this regulation. No prescription refills are permitted
for Schedule C-II drugs. Requiring refills by written prescription only applies to Schedule
C-II drugs. Schedule C-III prescriptions (written or oral) expire in 6 months.
A patient has been selected as a potential recipient of an experimental drug for multiple
sclerosis. The nurse knows that when informed consent has been obtained, it indicates
which of these?
a) The patient has been informed that he or she will need to stay in the study until it
ends.
b) The patient will be informed of the details of the study as the research continues.
c) The patient will receive the actual drug during the experiment.
d) The patient has had the study's purpose, procedures, and possible benefits as well as
risks involved explained to him. - CORRECT-ANSWERS ******d) The patient has had the
study's purpose, procedures, and possible benefits as well as risks involved explained to
him.
Informed consent involves the careful explanation of the purpose of the study, the
procedures to be used, and the risks involved. The other options do not describe
